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Abstract
The sixth International Conference on Intelligent Biology and Medicine (ICIBM) took place in Los Angeles, California,
USA on June 10–12, 2018. This conference featured eleven regular scientific sessions, four tutorials, one poster
session, four keynote talks, and four eminent scholar talks. The scientific program covered a wide range of topics
from bench to bedside, including 3D Genome Organization, reconstruction of large scale evolution of genomes
and gene functions, artificial intelligence in biological and biomedical fields, and precision medicine. Both method
development and application in genomic research continued to be a main component in the conference, including
studies on genetic variants, regulation of transcription, genetic-epigenetic interaction at both single cell and tissue level
and artificial intelligence. Here, we write a summary of the conference and also briefly introduce the four high quality
papers selected to be published in BMC Genomics that cover novel methodology development or innovative data
analysis.
Introduction
The 2018 International Conference on Intelligent Biology
and Medicine (ICIBM 2018) was held from June 10th to
12th, 2018 in Los Angeles, California, USA. This is the
sixth ICIBM conference and it became the first official
conference of The International Association for Intelligent
Biology and Medicine (IAIBM). Since its inception in
2012, ICIBM conference series aim to: 1) foster inter-
disciplinary and multidisciplinary research in bioinfor-
matics, systems biology, intelligent computing/artificial
intelligence, bioengineering, and data sciences, and 2)
offer an educational program for trainees and young
investigators in multiple scientific disciplines to learn
or exchange the new methods/tools/discoveries in these
areas and to build a professional network among both
the established and junior investigators.
We have expanded our ICIBM conference each year
since 2012. The summary of the previous conferences is
reported in previous introduction article [1–5]. The ICIBM
2018 was carefully prepared and attracted a record number
of the paper submission and participants, and was the
largest ICIBM conference. Specifically, we received 95
original manuscripts and 44 abstracts in the areas of
bioinformatics, genomics, systems biology, machine
learning, and biomedical informatics. Each paper was
carefully reviewed by the program committee members.
Among these submissions, we observed more papers
coming out from emerging fields such as deep learning,
new genome technologies, and big medical data science.
Accordingly, our keynote speeches and scientific sessions
reflect these trends. In addition, financial support from
National Science Foundation allowed us to support 20
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trainees in diverse background and across the world to
attend and present their works in the ICIBM conference.
As before, the Award Committee carefully reviewed travel
award applications based on the quality of the research
(paper or abstract), the financial need, and diversity/mi-
nority of the attendees. Below, we briefly summarize the
scientific program of the ICIBM 2018 and also provide an
introduction of the 4 research articles selected for this
BMC Genomics supplement issue.
Overall scientific program of ICIBM 2018
The ICIBM 2018 scientific program includes eleven
regular scientific sessions, four tutorials, one poster session,
four keynote talks, and four eminent scholar talks. It
covered a variety of the topics in bioinformatics, systems
biology, machine learning, data sciences, and biomedical
informatics.
Keynote and eminent scholar lectures
Four distinguished scientists were invited to deliver the
keynote speeches to the ICIBM attendees. These speakers
were: (1) Joshua C. Denny, MD, MS, a Professor of Bio-
medical Informatics and Medicine, Director of the Center
for Precision Medicine and Vice President of Personalized
Medicine at Vanderbilt University Medical Center. He is a
Fellow of the American College of Medical Informatics
and a member of the National Academy of Medicine.
He presented “Huge cohorts, genomics, and clinical
data to personalize medicine”. In his talk, Dr. Denny
demonstrated how electronic health records (EHRs)
and genomic data can be combined for phenome-wide
association studies, leading to personalized medicine. He
also introduced the era of huge international cohorts such
as the UK Biobank, Million Veteran Program, and the
newly started All of Us Research Program, which will make
millions of individuals available with dense molecular and
phenotypic data. (2) Paul D. Thomas, Ph.D., an Associate
Professor in the Preventive Medicine Department, and
who heads the Bioinformatics Division at the University of
Southern California Keck School of Medicine. Dr. Thomas
is the leader of the Gene Ontology project, which is among
the world’s largest bioinformatics projects. In Dr. Thomas
presentation entitled “Reconstructing the large-scale evolu-
tion of genomes and gene functions”, he gave an overview
of the reconstruction methods and the related findings,
introduced his work that reconstructed the evolutionary
history of over 1 million genes in 15,000 gene families
covering all domains of life, and also his work inferring
human gene function from experiments in “model organ-
isms” such as the fruit fly and yeast.
In the third keynote speech, Dr. Alexander Hoffmann, a
Professor of Microbiology, Immunology, and Molecular
Genetics, and Director of the Institute for Quantitative and
Computational Biosciences (QCB) at UCLA, demonstrated
“Learning how to predict immune responses”. He discussed
how molecular network dynamics and molecular noise
affect immune cell function, and some of the modeling
strategies that allow for prediction and insight. The
fourth keynote speaker was Dr. Jason Moore, who holds
the Edward Rose Professor of Informatics and Director
of the Penn Institute for Biomedical Informatics. He
also serves as Senior Associate Dean for Informatics
and Chief of the Division of Informatics in the Department
of Biostatistics, Epidemiology, and Informatics. Dr. Moore
is a fellow of the American Association for the Advance-
ment of Science (AAAS), the American College of Medical
Informatics (ACMI), the American Statistical Association
(ASA), and a Kavli fellow of the National Academy of
Sciences. In his presentation, entitled “Accessible artificial
intelligence for data science”, Dr. Moore introduced the
history of artificial intelligence (AI) and then demonstrated
the PennAI, an accessible, open-source, and user-friendly
AI system at the University of Pennsylvania. PennAI brings
AI and automated machine learning technology to every-
one who wants to incorporate this technology into their
big data analytics agenda.
ICIBM 2018 also featured four eminent scholar talks.
These talks were delivered by four renowned researchers
in their specific fields. (1) Dr. Xinghua Lu, a professor in
the Department of Biomedical Informatics, University of
Pittsburgh, presented “From big data to bedside (BD2B):
Precision oncology in an era of artificial intelligence”. (2)
Ting Wang, Ph.D., an Associate Professor of Genetics,
Computer Science and Engineering, and Biostatistics,
and the Director of Computational and Systems Biology
Program at Washington University School of Medicine,
talked about “Exploring the dark matter in genomics
data”. Dr. Xinshu (Grace) Xiao, a Professor and Vice Chair
of the Department of Integrative Biology and Physiology at
the University of California, Los Angeles, gave the presenta-
tion entitled “Deciphering the function of single-nucleotide
variants in the RNA”. Finally, Dr. Charles Wang, the found-
ing Director of the Center for Genomics and a professor in
the School of Medicine, Loma Linda University (LLU),
gave the lecture focusing on “Vegetarian diet-modulated
epigenetic reprogramming and longevity”.
ICIBM tutorials
As before, ICIBM offered tutorials to help trainees or other
investigators learn the frontier informatics technologies.
ICIBM 2018 provided four tutorials: Deep architectures are
not necessary for anomaly classification of matrix-formed
omics data (offered by Dr. Yan Guo, Associate & Endowed
Professor in Cancer Bioinformatics and Computational
Biology, Director of Bioinformatics Shared Resources,
Comprehensive Cancer Center University of New Mexico),
Single-cell sequencing analysis (offered by Dr. Chi Zhang,
Indiana University School of Medicine, and Dr. Xiao Dong,
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Albert Einstein College of Medicine), Workshop on 3D
genome organization (offered by Dr. Feng Yue, Director,
Bioinformatics Division, Institute for Personalized Medicine,
Penn State College of Medicine), and WashU Epigenome
Browser (offered by Dr. Ting Wang, Associate Professor
of Genetics and Computer Science and Engineering,
Washington University at St. Louis). All the tutorial lec-
turers are the experts in the related techniques or tools, or
the developers of the tools.
Scientific sessions
ICIBM 2018 included eleven concurrent scientific sessions
and one poster session. Speakers in the regular sessions
were chosen from those top ranked manuscripts after peer
review. The topics in these session covered bioinformatics,
genomics, systems biology, intelligent computing, data
sciences, computational drug discovery, and biomedical
informatics. To promote international collaboration, we
first time organized an International PI talk session.
Several principal investigators (PIs) from oversea presented
their exciting projects in this session followed by extensive
discussion. In addition, two best papers were selected and
honored in the conference. The eleven session are:
Session I: NGS & Tools I
Session II: Systems Biology I
Session III: Bioinformatics
Session IV: NGS & Tools II
Session V: Systems Biology II
Session VI: Medical Informatics
Session VII: Cancer Genomics I
Session VIII: Systems Biology III
Session IX: Computational Drug Discovery
Session X: International PI Talk
Session XI: Cancer Genomics II
The science program for the ICIBM 2018 genomics
track
Since 2010, ICIBM meetings have been covering the latest
developments in the entire pipeline of genomics research
from low level data processing, to modeling, prediction and
visualization, as well as to application to the real data sets.
The tasks have grown from single feature to network ana-
lysis, and the scale of studies have grown from single data
set to joint analysis of large scale cohorts or integration of
data from multiple types and sources. The ICIBM 2018
reflects the trend to harvesting signal from increasing
amount of data and keeping the development of computa-
tional methods to meet the needs of emerging biotech-
nology that presents new data types. Below, we summarize
the contribution of ten papers included in this supplement
issue.
The paper by Du et al. [6] explored the idea of gene
embedding, distributed representation of genes, in the
spirit of word embedding. The authors described a machine
learning method that uses transcriptome-wide gene co-ex-
pression patterns from 984 publicly available data sets to
generate a distributed representation of genes. They trained
a vector representation (vectors of dimension 200) of all
human genes, which captured functional relatedness of
genes in terms of recovering known-pathways. The use-
fulness of the embedded gene vectors is illustrated in
tasks such as gene-gene interaction prediction based
solely on gene names.
RNA-sequencing (RNA-seq) has now become a routine
technique in genomic studies and its application has
expanded beyond quantifying transcription activity.
Mohammad et al. [7] introduced a cell line identification
method using variants derived from RNA-seq data.
They calculated pair-wise correlations based on fre-
quencies and depth of coverage values of variants and
conducted comparative analysis of correlations across
cell lines. The results showed substantial difference in
variant profiles between different cell lines. On the
other hand, identical, synonymous and derivative cell
lines could share high variant identity and were highly
correlated. Their identification method, CeL-ID, has high
accuracy of identifying the cell line when a pure cell line is
involved, and can be used to detect cross-contamination
with a mixture model.
Emerging technologies that bring in new data types
have become a constant phenomenon in the genomics
era. The paper by Liu et al. [8] presents a computational
method to detect DNA modification from single-molecule
sequencing data generated by Nanopore technology. This
method, named NanoMod, takes Nanopore sequencing
data on paired DNA samples with and without modifica-
tions, and identifies modified bases by contrasting the
signal distributions in the two samples and adjusting for
local neighborhood effects. Not only does NanoMod show
improved performance in the detection of DNA modifica-
tion in simulation studies, but also its ability to detect de
novo modification without training data makes it particu-
larly desirable.
In addition to technology advancement, innovative
analysis using existing datasets continue to bring discoveries.
Pei et al. [9] investigated multi-trait associations using
genome-wide association studies (GWAS) datasets. Specific-
ally, the authors applied pathway-based analysis of GWAS
summary statistics with an analytical framework for
systematic integration of cross-trait associations. They
used 25 traits belonging to four phenotype groups. The
pathway-based analysis provided increased power to
estimate cross-trait associations compared to gene-level
analysis. The study revealed that the risk variants to the
25 different traits aggregated in particular biological
pathways and that these pathways were frequently shared
among traits. The results confirmed known mechanisms
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and also suggested several novel insights into the etiology of
multi-traits.
Conference organization
2018 International conference on intelligent biology and
medicine (ICIBM 2018)
(June 10–12, 2018 Los Angeles, California, USA)
We would like to express our sincere gratitude to the
members of the Steering, Program, Publication, Workshop/
Tutorial, Publicity, Award, Trainee and Local Organization
Committees, as well as to all the reviewers, volunteers and
invited speakers, who spent their valuable time and effort
on making ICIBM 2018 a success. The conference accom-
plishments are the results of support and hard work of all
these people.
Hosts and sponsors
The International Association for Intelligent Biology
and Medicine (IAIBM), The University of Texas Health
Science Center at Houston (UTHealth), National Science
Foundation, UTHealth Center for Precision Health, and
UTHealth Data Science and Informatics Core for Cancer
Research.
General Chair Zhongming Zhao (The University of
Texas Health Science Center at Houston).
Steering Committee Yidong Chen (The University of
Texas Health Science Center at San Antonio), Kun Huang
(Indiana University), Tony Hu (Drexel University), Lang
Li (The Ohio State University), Yi Xing (University of
California Los Angeles), Jiajie Zhang (The University of
Texas Health Science Center at Houston), Wenjin J.
Zheng (The University of Texas Health Science Center
at Houston).
Program Committee Chair: Kai Wang (Children’s
Hospital of Philadelphia), Co-Chair: Degui Zhi (The
University of Texas Health Science Center at Houston).
Members: Genevera Allen (Rice University), Jianlin Cheng
(University of Missouri Columbia), Luca Giancardo (The
University of Texas Health Science Center at Houston),
Assaf Gottlieb (The University of Texas School of Biomed-
ical Informatics at Houston), Mike Guo (University of
New Mexico), Yan Guo (University of New Mexico), Zhi
Han (Indiana University School of Medicine), Matthew
Hayes (Xavier University of Louisiana), Kun Huang
(The Ohio State University), Weichun Huang (National
Institute of Environmental Health Sciences), Yang Huang
(Kaiser Permanente), Yufei Huang (University of Texas at
San Antonio), Zhi-Linag Ji (Xiamen University, China),
Peilin Jia (The University of Texas Health Science Center
at Houston), Victor Jin (University of Texas at San
Antonio), Yufang Jin (University of Texas at San
Antonio), Jun Kong (Emory University), Dmitry Korkin
(Worcester Polytechnic Institute), Rui Kuang (University
of Minnesota Twin Cities), K.B. Kulasekera (University of
Louisville), Qiwei Li (Rice University), Fuhai Li (The Ohio
State University), Tao Li (Nankai University, China),
Zhaohui Li (Nankai University, China), Aimin Li (Xi’an
University of Technology, China), Ping Liang (Brock
University, Canada), Liao Li (University of Delaware),
Honghuang Lin (Boston University), Nan Liu (Chinese
Academy of Sciences, China), Yin Liu (The University
of Texas Health Science Center at Houston), Xiaoming
Liu (The University of Texas Health Sciences Center at
Houston), Yunlong Liu (Indiana University), Zhandong
Liu (Baylor College of Medicine), Zhiyong Lu (NCBI,
National Library of Medicine, NIH), Mirjana Maletic
(Baylor College of Medicine), Patricio A Manque (Univer-
sidad Mayor, Chile), Huaiyu Mi (University of Southern
California), Nitish Mishra (University of Nebraska Med-
ical Center), Qiangxing Mo (Baylor College of Medicine),
Tabrez Mohammad (The University of Texas Health Sci-
ence Center at San Antonio), Hatice Ozer (Ohio State
University), Ranadip Pal (Texas Tech University), Jiang
Qian (Johns Hopkins University), Guimin Qin (Xidian
University), Thomas Rindflesch (National Institutes of
Health), Jianhua Ruan (The University of Texas at San
Antonio), Bairong Shen (Soochow University, China),
Xiaofeng Song (Nanjing University of Aeronautics and
Astronautics, China), Fengzhu Sun (University of Southern
California), Wing-Kin Sung (National University of
Singapore, Singapore), Manabu Torii (Kaiser Permanente),
Ying-Wooi Wan (Baylor College of Medicine), Jun Wan
(Indiana University), Yufeng Wang (University of Texas at
San Antonio), Junbai Wang (Radium Hospital), Qingguo
Wang (Memorial Sloan Kettering Cancer Center), Jiaying
Wang (Xian Jiaotong University, China), Chaochun Wei
(Shanghai Jiao Tong University, China), Xiwei Wu (City of
Hope National Medical Center), Yonghui Wu (University
of Florida), Zhijin Wu (Brown University), Junfeng Xia
(Anhui University, China), Lu Xie (Shanghai Center
for Bioinformation Technology, China), Lei Xie (City
University of New York), Hua Xu (The University of
Texas Health Science Center at Houston), Jianhua
Xuan (Virginia Tech), Yu Xue (Huazhong University
of Science and Technology, China), Zhenqing Ye (The
University of Texas Health Science Center at San
Antonio), Sungroh Yoon (Seoul National University,
Korea), Feng Yue (Penn State University), Habil Zare
(Texas State University), Rui Zhang (University of
Minnesota), Shaojie Zhang (University of Central Flor-
ida), Han Zhang (Nankai University, China), Bing
Zhang (Baylor College of Medicine), Zhongming Zhao
(The University of Texas Health Science Center at
Houston), Min Zhao (University of the Sunshine Coast,
Australia), Jim W. Zheng (The University of Texas Health
Science Center at Houston), Xianghong Zhou (University
of California Los Angeles), Yunyun Zhou (University of
Mississippi).
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Publication Committee Chair: Zhijin Wu (Brown Uni-
versity), Co-Chair: Jianhua Ruan (The University of Texas
at San Antonio).
Workshop/Tutorial Committee Chair: Feng Yue
(Pennsylvania State University), Co-Chair: Yan Guo
(University of New Mexico).
Publicity Committee Chair: Lana Garmire (University
of Hawaii), Co-Chair: Sun Kim (Seoul National University,
Korea), Co-Chair: Yu Xue (Huazhong University of
Science and Technology, China).
Award Committee Chair: Fuhai Li (Ohio State Univer-
sity), Co-Chair: Lei Xie (City University of New York).
Trainee Committee Chair: Abolfazl Doostparast
(Columbia University), Co-Chair: Qian Liu (Children’s
Hospital of Philadelphia).
Local Organization Committee Chair: Jessica Li
(University of California Los Angeles), Co-Chair: Matteo
Pellegrini (University of California Los Angeles), Co-Chair:
Xiaoming Liu (The University of Texas Health Science
Center at Houston).
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